West Pharmaceutical Services (WST) Current Assets (2009 - 2026)

West Pharmaceutical Services' Current Assets history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Current Assets rose 25.34% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 25.34% YoY), while the FY2025 annual figure was $2.0 billion, up 28.61% from the prior year.
• Current Assets came in at $1.8 billion for Q1 2026 at West Pharmaceutical Services, down from $2.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.0 billion in Q4 2025 to a low of $1.5 billion in Q1 2025.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets dropped 21.38% in 2024 and advanced 28.61% in 2025, its largest moves.
• West Pharmaceutical Services' Current Assets stood at $1.9 billion in 2022, then advanced by 0.88% to $1.9 billion in 2023, then fell by 20.57% to $1.5 billion in 2024, then rose by 28.61% to $2.0 billion in 2025, then decreased by 7.65% to $1.8 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $1.8 billion, $2.0 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison